European drugmakers say they are ‘losing ground’ to US and Chinese rivals
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"European drugmakers say they are ‘losing ground’ to US and Chinese rivals" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include CORDIS | European Commission, Reuters, Bloomberg.com and Fierce Pharma. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 45d ago.
Quick answers
Why is "European drugmakers say they are ‘losing ground’ to US and Chinese rivals" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- Europe Is Losing the Pharma Investment Race — But the Comeback Is Within Reach: An open letter from the Chairs of AstraZeneca, Boehringer Ingelheim, Chiesi Group, Ipsen, GSK, Novo, Novartis, Roche, and Sanofi AstraZeneca · 45d ago
- European pharma's 'slow agony' of decline draws warning from nine industry chairs FirstWord · 45d ago
- Horizon is powering the EU’s biotechnology industry, from innovation to investment CORDIS | European Commission · 45d ago
- European drugmakers call for faster trials, more spending to compete with US, China Reuters · 45d ago
- Pharma Bosses Warn European Leaders Future Investment at Risk Bloomberg.com · 45d ago
- 'Europe does not value what you do': 9 pharmas make urgent call for bloc to beef up innovation muscle Fierce Pharma · 45d ago
- European drugmakers say they are ‘losing ground’ to US and Chinese rivals theguardian.com · 45d ago
Topics
Related trends
US believes Nvidia’s Huang had romantic relationship with alleged Chinese spy
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Jared Kushner’s European security plan isn’t convincing Europe
1 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
US lawmakers summon Jensen Huang over Chinese spying concerns
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Newsroom bomb threats follow escalating European flight hoaxes
2 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
US Proposes New European Security Framework
6 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
Trump's European Far-Right Allies Suddenly Have A Problem With Him
European far-right leaders are distancing themselves from Trump following midterm losses, according to recent coverage.